Bayer AG said third-quarter sales fell nearly 3 percent as it stopped reporting results from Covestro, the plastics and materials segment it spun off two years ago.

The German drug maker said sales were 8.03 billion euros ($9.4 billion), missing analysts’ projections of 8.4 billion euros.

Net income rose to 3.4 billion euros, including a gain from divesting Covestro.

Bayer is now reporting Covestro as a discontinued operation.

Advertise with us

Bayer spun off the unit, which has its North American headquarters in Robinson, saying it wanted to focus on pharmaceuticals and its agricultural chemicals segments. It now owns less than 25 percent of Covestro shares.

Bayer has about 1,600 employees in the Pittsburgh region, including 600 in administrative jobs in Robinson and 1,000 who work for a unit of Bayer HealthCare that makes medical devices.

Bayer said it expects to close on its $66 billion acquisition of seed producer Monsanto early next year.

Joyce Gannon: jgannon@post-gazette.com or 412-263-1580.